Position in PFE
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$229,988
+$21,466 QoQ
Shares Held
9,551
+28.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#2,337
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Congress Park Capital LLC holds $10,199,729 across 8 Drug Manufacturers - General names. PFE ranks #7 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,607 | $4,326,344 | |
| 2 | AMGN |
Amgen Inc
|
5,130 | $1,857,675 | |
| 3 | JNJ |
Johnson & Johnson
|
6,838 | $1,736,646 | |
| 4 | ABBV |
AbbVie Inc.
|
3,637 | $915,214 | |
| 5 | MRK |
Merck & Co., Inc.
|
5,060 | $650,210 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,225 | $281,106 | |
| 7 | PFE |
Pfizer Inc
This page
|
9,551 | $229,988 | |
| 8 | NVO |
Novo Nordisk A S
|
4,225 | $202,546 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $229,988 | 9,551 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $208,522 | 7,426 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $222,257 | 8,926 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $227,434 | 8,926 | Shares | Sole | 2025-10-08 | |
| 2025-06-30 | $207,276 | 8,551 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $203,100 | 8,015 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $225,902 | 8,515 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $268,129 | 9,265 | Shares | Sole | 2024-10-09 | |
| 2024-06-30 | $325,687 | 11,640 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $600,510 | 21,640 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $565,435 | 19,640 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $880,497 | 26,545 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $922,355 | 25,146 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $974,630 | 23,888 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $1,057,491 | 20,638 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $883,426 | 20,188 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $930,003 | 17,738 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $859,433 | 16,601 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $1,122,009 | 19,001 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $806,480 | 18,751 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $724,499 | 18,501 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $652,176 | 18,001 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $599,119 | 16,276 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $542,278 | 14,776 | Shares | Sole | 2020-10-20 | |
| 2020-06-30 | $407,278 | 12,455 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $356,754 | 10,930 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||